Avid Bioservices Inc (CDMO)

[oddone33320]

Agreed BioBS, p values are irrelevant at this point as they will only need to worry about that in the PH III trial. I have been sharing the Peregrine developments with a friend who is a clinical trial manager and she has confirmed that showing statistical significance is only imperative in PH III trials and that the data she has seen in the press releases certainly looks good enough in her opinion to warrant approval of a PH III trial by the FDA.


Don't forget about the 1st line NSCLC results due before the end of June. I wouldn't be surprised if they were ready for release in time for ASCO at the end of May. 3 months is not that far off although it is tough to watch the share price drop after reinforcement of very positive 2nd line NSCLC trial results. Assuming results for the 1st line trial are also extraordinary, if there isn't a partnership inked by the time that data is released then Peregrine should have the upper hand in any negotiations after that point. Despite the way the share price has tanked over the past couple of days, I believe we'll be testing the highs again by the start of summer.

All IMO.